瑜伽锻炼对慢性非细菌性前列腺炎/慢性骨盆疼痛综合征的辅助康复治疗效果

Yoga on chronic non-bacterial prostatitis/ chronic pelvic pain rehabilitation assistance syndrome

目的:探讨瑜伽锻炼对慢性非细菌性前列腺炎/慢性骨盆疼痛综合征(CAP/CPPS)的辅助康复治疗效果。方法:将2008年4月～2010年4月期间符合CAP/CPPS诊断标准的200名患者,随机分为对照组和实验组。对照组采用常规治疗方法,实验组采用在常规治疗的基础上辅以瑜伽锻炼,每周5次,每次40 min左右,以患者不感疲劳为限。采用问卷调查方式,二组患者在治疗前、治疗1个月、治疗3个月予前列腺炎症状指数评分;测定二组患者在治疗前、治疗1个月、治疗3个月的最大尿流率及精浆IL-1、TNF-α水平;统计治愈率、总有效率。结果:实验组患者治疗1个月、治疗3个月前列腺炎症状指数评分、最大尿流率及精浆IL-1、TNF-α水平,与对照组比较具有统计学意义(P<0.05)。实验组治愈率(67%)和总有效率(82%)均明显高于对照组治愈率(67%)、总有效率(68%),P<0.05。结论:CAP/CPPS患者在常规治疗的基础上辅以瑜伽体育锻炼,效果显著。

Objective To explore Yoga in assisted rehabilitation therapy on chronic non-bacterial prostatitis / chronic pelvic pain syndrome.Methods 200 patients were randomly divided into control and experimental groups from April 2008 to April 2010.Experimental group,on the basis of routine treatment,were supplemented by Yoga exercise,every 40 minutes and 5 times a week.The patients do not feel the fatigue limit.A questionnaire survey method,the control group and experimental group of patients before treatment,1 month,3 months for treatment of chronic prostatitis symptom index score;determination of the control group and experimental group patients before treatment,1 month,treatment 3.Results In the control group and experimental group patients 1 month,3 months treatment of chronic prostatitis symptom index score,maximum flow rate and the seminal plasma IL-1,TNF-α levels,statistical test between two groups P <0.05,there statistically significant difference.Control group,experimental group cure rates were 51% and 67%;control group,experimental group,the total effective rate was 68% and 82%.The test statistic,P <0.05,there was a significant difference.Control patients before treatment,1 month and 3 months treatment prostatitis symptom index score,maximum flow rate and the seminal plasma IL-1,TNF-α levels,statistical t test between two groups P <0.05,significantly.Conclusion CAP/CPPS patients on the basis of conventional treatment combined with Yoga exercise,the effect is significant.